openPR Logo
Press release

Apheresis Market on Track to Hit USD 3.50 Billion by 2030, Growing at 7.82 Percentage CAGR

Apheresis Market

Apheresis Market

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ CAGR is expected to be 7.82% during the forecast period and the market size is expected to reach nearly US$ 3.50 Bn. by 2030.

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

The apheresis market is experiencing robust growth due to its vital role in therapeutic and donor blood collection procedures. Apheresis is a medical technology where blood is drawn from a donor or patient, separated into its components, and selectively retained or returned. This process is widely used in treating autoimmune diseases, blood disorders, and managing conditions like leukemia and multiple myeloma. The growing prevalence of chronic diseases, coupled with increasing demand for blood components like plasma, platelets, and red blood cells, is driving market expansion. Technological advancements in apheresis devices, including automated and portable systems, have enhanced efficiency and patient safety, further fueling market growth. Rising awareness of the importance of plasma donation and government initiatives supporting blood donation drives are additional factors contributing to the marketu2019s development. With increasing healthcare investments in emerging economies and a growing geriatric population prone to hematological conditions, the apheresis market is poised for significant advancements in the coming years.

๐†๐ž๐ญ ๐˜๐จ๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐ญ๐ก๐ž ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/request-sample/12723/

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

The apheresis market is driven by multiple factors, including the rising prevalence of chronic diseases and the increasing demand for plasma-derived therapies. The surge in autoimmune disorders, such as Guillain-Barru00e9 syndrome and myasthenia gravis, has heightened the demand for therapeutic apheresis procedures. Growing investments in healthcare infrastructure and R&D for advanced apheresis devices are fostering market growth. The demand for safe and efficient blood component separation techniques has led to the widespread adoption of automated apheresis systems. Additionally, the increasing awareness of the benefits of blood and plasma donation has boosted donor participation, particularly in developed regions. Government initiatives and supportive policies, such as funding for blood donation campaigns and reimbursement for apheresis procedures, are further driving the market. The need for efficient treatment options for hematological disorders and improved healthcare access in emerging economies also contribute significantly to the expansion of the apheresis market.

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Several trends are shaping the growth of the apheresis market. One of the key trends is the development of portable and user-friendly apheresis devices, enabling point-of-care treatments and expanding the scope of apheresis in homecare settings. The integration of artificial intelligence and machine learning in apheresis systems is enhancing efficiency, accuracy, and personalization of treatments. Another emerging trend is the increasing focus on donor safety, leading to innovations in disposable kits and real-time monitoring systems. The rise of therapeutic plasma exchange (TPE) for treating neurological and autoimmune disorders is gaining momentum, driven by improved outcomes and growing clinical adoption. Collaborations between healthcare providers and medical device manufacturers are fostering innovation, resulting in cost-effective and advanced solutions. Additionally, the push for sustainable and environmentally friendly practices in healthcare has prompted companies to develop energy-efficient apheresis machines. The expansion of plasma collection centers in emerging economies further highlights the global shift towards meeting the rising demand for plasma-derived therapies.

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐“๐จ๐๐š๐ฒ ๐Ÿ๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ: https://www.maximizemarketresearch.com/inquiry-before-buying/12723/

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐•๐ข๐ž๐ญ๐ง๐š๐ฆ: ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Vietnam's healthcare sector is experiencing a surge in demand for apheresis devices, driven by growing awareness of blood and plasma donation. Government initiatives to improve healthcare infrastructure are creating opportunities for local and international players. Companies like Haemonetics Corporation are actively collaborating with Vietnamese medical institutions to expand access to advanced apheresis solutions. With increasing investments in plasma collection centers, Vietnam is emerging as a key market in Southeast Asia.

๐“๐ก๐š๐ข๐ฅ๐š๐ง๐: ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Thailand's apheresis market is flourishing, supported by its robust healthcare system and rising medical tourism. The country has seen significant investments from global players such as Terumo BCT, who are introducing innovative apheresis technologies tailored for local needs. The adoption of therapeutic plasma exchange (TPE) for treating neurological and autoimmune disorders is on the rise, reflecting global trends in advanced medical treatments.

๐‰๐š๐ฉ๐š๐ง: ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Japan continues to lead in medical innovation, with its apheresis market benefiting from strategic consolidations. Companies such as Asahi Kasei Medical Co. Ltd. are expanding their product portfolios through mergers and acquisitions. Japan's aging population and the rising incidence of blood-related disorders have created a strong demand for advanced apheresis solutions. Government support for medical R&D and healthcare advancements further bolsters the market.

๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š: ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

South Korea's focus on advanced healthcare technologies has propelled the growth of its apheresis market. Leading companies like JW Bioscience are investing heavily in R&D to develop cost-effective and innovative apheresis devices. Recent collaborations with global firms have strengthened the country's position as a manufacturing hub for high-quality medical equipment. The increasing prevalence of autoimmune diseases and hematological conditions is driving market demand.

๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž: ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Singapore's strategic focus on healthcare innovation and infrastructure development is driving growth in the apheresis market. Collaborations between local hospitals and global companies such as Fresenius Kabi are enhancing access to advanced apheresis technologies. Singapore's emphasis on precision medicine and clinical trials is fostering the adoption of therapeutic apheresis for treating complex medical conditions, solidifying its position as a key player in the region.

๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ: ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The United States remains the largest market for apheresis devices, driven by a strong healthcare system, significant R&D investments, and the presence of major industry players like Baxter International Inc.. The country is witnessing increasing adoption of AI-integrated apheresis systems, which enhance procedural efficiency and patient outcomes. Recent mergers, such as Fresenius Kabi's acquisition of a U.S.-based plasma collection firm, highlight consolidation trends shaping the market.

๐„๐ฎ๐ซ๐จ๐ฉ๐ž: ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Europe's apheresis market is evolving rapidly, with a focus on sustainability and innovation. Leading countries like Germany and the UK are investing in eco-friendly apheresis solutions to minimize environmental impact. Companies such as Macopharma are expanding their European operations by launching advanced disposable kits and portable devices. Collaborative efforts between research institutions and medical device manufacturers are driving technological advancements across the region.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ? ๐†๐ซ๐š๐› ๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐“๐จ๐๐š๐ฒ: https://www.maximizemarketresearch.com/request-sample/12723/

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

by Product

Apheresis Devices
Plasma Separators
Plasma Component Separators
Immunoadsorption Columns
Plasma Perfusion Columns
Hemoperfusion Columns
Apheresis Disposables
Apheresis Market, by Procedure
Automated/Apheresis Blood Collection (Donor Apheresis)
Therapeutic Apheresis

by Disease

Neurological Disorders
Blood Disorders
Cardiovascular Disorders
Renal Disorders
Autoimmune Disorders
Metabolic Disorders
Other Disorders

by Procedure

Therapeutic Plasma Exchange (TPE)
Therapeutic Cytapheresis
Therapeutic Erythrocytapheresis
Therapeutic Plateletpheresis
Leukapheresis
Photopheresis
Extracorporeal Immunoadsorption (ECI)

by Technology

Centrifugation
Intermittent Flow
Continuous Flow
Membrane Separation

by Application

Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Applications

๐–๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž?

1. Haemonetics Corporation
2. Fresenius Medical Care
3. Terumo BCT, Inc.
4. Asahi Kasei Medical Co., Ltd.
5. Kawasumi Laboratories Inc.
6. Cerus Corporation
7. B. Braun Melsungen AG
8. HemaCare Corporation
9. Kaneka Corporation
10. Nikkiso Co., Ltd.

๐Š๐ง๐จ๐ฐ ๐Œ๐จ๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐“๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/market-report/apheresis-market-global/12723/

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐Œ๐จ๐ซ๐ž: ๐•๐ข๐ฌ๐ข๐ญ ๐Ž๐ฎ๐ซ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž ๐Ÿ๐จ๐ซ ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

โ™ฆGlobal Marine Fuel Additives Market https://www.maximizemarketresearch.com/market-report/global-marine-fuel-additives-market/83616/

โ™ฆGlobal Zinc Nickel Alloy Plating Market https://www.maximizemarketresearch.com/market-report/global-zinc-nickel-alloy-plating-market/54372/

โ™ฆGlobal Out of Autoclave Prepregs Market https://www.maximizemarketresearch.com/market-report/global-out-of-autoclave-prepregs-market/78338/

โ™ฆGlobal Automotive Power Glass Sunroof Market https://www.maximizemarketresearch.com/market-report/global-automotive-power-glass-sunroof-market/26393/

โ™ฆGlobal Off Road Fuels Market https://www.maximizemarketresearch.com/market-report/off-road-fuels-market/107489/

โ™ฆGlobal Nano Films Market https://www.maximizemarketresearch.com/market-report/global-nano-films-market/107979/

โ™ฆGlobal Isophorone Diisocyanate Market https://www.maximizemarketresearch.com/market-report/global-isophorone-diisocyanate-market/82716/

MAXIMIZE MARKET RESEARCH PVT. LTD.

โฎ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

โœ† +91 9607365656

๐Ÿ–‚ sales@maximizemarketresearch.com

๐ŸŒ www.maximizemarketresearch.com

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Apheresis Market on Track to Hit USD 3.50 Billion by 2030, Growing at 7.82 Percentage CAGR here

News-ID: 3823810 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
The Courier Services Market size was valued at USD 453.56 Billion in 2024 and the total Courier Services revenue is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 712.07 Billion. Courier Services Market Overview The global Courier Services Market has experienced significant growth, driven by the rising adoption of e-commerce, growing Internet penetration, and changing consumer lifestyles. Courier services provide quick, door-to-door delivery solutions forโ€ฆ
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market was valued at USD 6.47 Billion in 2023, and it is expected to reach USD 17.83 Billion by 2030, exhibiting a CAGR of 15.58% during the forecast period (2024-2030). WealthTech Solutions Market Overview The global WealthTech Solutions Market is undergoing a transformative phase, driven by changing customer preferences, digital innovation, and evolving financial landscapes. WealthTech solutions provide digital tools and platforms that enhance operational efficiency for financial advisors, wealthโ€ฆ
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR Growth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR G โ€ฆ
Global Rapid Test Market size was valued at USD 40.75 Bn. in 2024 and the total Rapid Test Market is expected to grow by 8.81% from 2025 to 2032, reaching nearly USD 80.07 Bn. Rapid Test Market Overview The global Rapid Test Market is witnessing significant growth, driven by the increasing demand for fast, accessible diagnostic solutions across healthcare settings and home-care applications. Rapid tests are designed to detect the presence ofโ€ฆ
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAGR Growth
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAG โ€ฆ
Global Agarwood Oil Market size is expected to reach nearly US$ 496.84 Mn by 2032 with the CAGR of 5.42% during the forecast period. Agarwood Oil Market Overview Agarwood Oil, derived from the resinous wood of Aquilaria trees primarily found in Southeast Asia, is highly valued for its aromatic and therapeutic properties. Formed when the wood is infected by yeast, pests, or microbes, the oil possesses antimicrobial, antioxidant, anti-inflammatory making it widelyโ€ฆ

All 5 Releases


More Releases for Apheresis

Apheresis Market Worth $3.9 billion | MarketsandMarketsโ„ข
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarketsโ„ข. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasingโ€ฆ
Apheresis Market Worth $3.9 billion | MarketsandMarkets Trademark
Browse 376 market data Tables and 65 Figures spread through 343 Pages and in-depth TOC on "Apheresis Market by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2029 Apheresis Market [https://www.prnewswire.com/news-releases/apheresis-market-worth-3-9-billion--marketsandmarkets-302115226.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at aโ€ฆ
Apheresis Equipment Market - Efficiency, Safety, Success: Apheresis Equipment Sh โ€ฆ
Newark, New Castle, USA: The "Apheresis Equipment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Apheresis Equipment Market: https://www.growthplusreports.com/report/apheresis-equipment-market/8509 This latest report researches the industry structure, sales, revenue,โ€ฆ
Apheresis Equipment Market Report Up to 2031
Visiongain has published a new report on Apheresis Equipment Market Report to 2031. Market is segmented by Product (Disposable apheresis kits, Apheresis machines), by Procedure (Plasmapheresis, Erythrocytaphereswis, Plateletpheresis, Leukapheresis), by Application (Renal diseases, Neurology, Hematology, Others), By Technology (Membrane filtration, Centrifugation). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Apheresis Equipment Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample ofโ€ฆ
Apheresis Market Size to Reach Valuation of $4.20 Billion by 2023 | Automated Ap โ€ฆ
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availabilityโ€ฆ
Apheresis Market (Therapeutic Apheresis & Donor Apheresis): Trends, Opportunitie โ€ฆ
Global Apheresis Market: Overview Apheresis, also known as pheresis and hemapheresis refers to a procedure that comprises extraction of blood from a donor and separating and preserving its components such as leukocytes, platelets, and plasma. Henceforth, the rest of the components are transfused back into the body of the donor. In this process, several abnormal components are also removed from the blood. The apheresis market is categorized from both the therapeuticโ€ฆ